{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,2]],"date-time":"2026-05-02T01:25:53Z","timestamp":1777685153960,"version":"3.51.4"},"reference-count":211,"publisher":"SAGE Publications","issue":"4","license":[{"start":{"date-parts":[[2019,10,24]],"date-time":"2019-10-24T00:00:00Z","timestamp":1571875200000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JHD"],"published-print":{"date-parts":[[2019,10,24]]},"DOI":"10.3233\/jhd-190372","type":"journal-article","created":{"date-parts":[[2019,9,27]],"date-time":"2019-09-27T14:11:51Z","timestamp":1569593511000},"page":"375-391","source":"Crossref","is-referenced-by-count":36,"title":["The Role of Hypothalamic Pathology for Non-Motor Features of Huntington\u2019s Disease"],"prefix":"10.1177","volume":"8","author":[{"given":"Rachel Y.","family":"Cheong","sequence":"first","affiliation":[{"name":"Translational Neuroendocrine Research Unit, Department of Experimental Medical Science, Lund University, Lund, Sweden"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sanaz","family":"Gabery","sequence":"additional","affiliation":[{"name":"Translational Neuroendocrine Research Unit, Department of Experimental Medical Science, Lund University, Lund, Sweden"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"\u212bsa","family":"Peters\u00e9n","sequence":"additional","affiliation":[{"name":"Translational Neuroendocrine Research Unit, Department of Experimental Medical Science, Lund University, Lund, Sweden"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"179","reference":[{"issue":"4","key":"10.3233\/JHD-190372_ref1","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1038\/nrneurol.2014.24","article-title":"Huntington disease: Natural history, biomarkers and prospects for therapeutics","volume":"10","author":"Ross","year":"2014","journal-title":"Nat Rev Neurol"},{"issue":"12","key":"10.3233\/JHD-190372_ref2","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1016\/j.biopsych.2006.11.034","article-title":"Psychiatric symptoms in Huntington\u2019s disease before diagnosis: The predict-HD study","volume":"62","author":"Duff","year":"2007","journal-title":"Biol Psychiatry"},{"issue":"1","key":"10.3233\/JHD-190372_ref3","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1037\/a0020937","article-title":"Neurocognitive signs in prodromal Huntington disease","volume":"25","author":"Stout","year":"2011","journal-title":"Neuropsychology"},{"issue":"1","key":"10.3233\/JHD-190372_ref4","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/S1474-4422(10)70276-3","article-title":"Biological and clinical changes in premanifest and early stage Huntington\u2019s disease in the TRACK-HD study: The 12-month longitudinal analysis","volume":"10","author":"Tabrizi","year":"2011","journal-title":"Lancet Neurol"},{"issue":"4","key":"10.3233\/JHD-190372_ref5","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1176\/jnp.2007.19.4.441","article-title":"Psychopathology in verified Huntington\u2019s disease gene carriers","volume":"19","author":"van Duijn","year":"2007","journal-title":"J Neuropsychiatry Clin Neurosci"},{"issue":"3","key":"10.3233\/JHD-190372_ref6","doi-asserted-by":"crossref","first-page":"355","DOI":"10.3233\/JHD-180293","article-title":"Clinical management of neuropsychiatric symptoms of Huntington disease: Expert-based consensus guidelines on agitation, anxiety, apathy, psychosis and sleep disorders","volume":"7","author":"Anderson","year":"2018","journal-title":"J Huntingtons Dis"},{"issue":"Pt 5","key":"10.3233\/JHD-190372_ref7","doi-asserted-by":"crossref","first-page":"1647","DOI":"10.1093\/brain\/119.5.1647","article-title":"Loss of disgust. Perception of faces and emotions in Huntington\u2019s disease","volume":"119","author":"Sprengelmeyer","year":"1996","journal-title":"Brain"},{"issue":"4","key":"10.3233\/JHD-190372_ref8","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1016\/j.neuropsychologia.2005.07.003","article-title":"Disgust in pre-clinical Huntington\u2019s disease: A longitudinal study","volume":"44","author":"Sprengelmeyer","year":"2006","journal-title":"Neuropsychologia"},{"issue":"Pt 7","key":"10.3233\/JHD-190372_ref9","doi-asserted-by":"crossref","first-page":"1732","DOI":"10.1093\/brain\/awm107","article-title":"Beyond disgust: Impaired recognition of negative emotions prior to diagnosis in Huntington\u2019s disease","volume":"130","author":"Johnson","year":"2007","journal-title":"Brain"},{"issue":"8","key":"10.3233\/JHD-190372_ref10","doi-asserted-by":"crossref","first-page":"2152","DOI":"10.1016\/j.neuropsychologia.2008.02.025","article-title":"Defective emotion recognition in early HD is neuropsychologically and anatomically generic","volume":"46","author":"Henley","year":"2008","journal-title":"Neuropsychologia"},{"issue":"5","key":"10.3233\/JHD-190372_ref11","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1017\/S1355617717001308","article-title":"Emotion recognition correlates with social-neuropsychiatric dysfunction in Huntington\u2019s disease","volume":"24","author":"Kempnich","year":"2018","journal-title":"J Int Neuropsychol Soc"},{"issue":"12","key":"10.3233\/JHD-190372_ref12","doi-asserted-by":"crossref","first-page":"1411","DOI":"10.1136\/jnnp-2013-307343","article-title":"Neuropsychiatric symptoms in a European Huntington\u2019s disease cohort (REGISTRY)","volume":"85","author":"van Duijn","year":"2014","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"1","key":"10.3233\/JHD-190372_ref13","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1523\/JNEUROSCI.3842-04.2005","article-title":"Disintegration of the sleep-wake cycle and circadian timing in Huntington\u2019s disease","volume":"25","author":"Morton","year":"2005","journal-title":"J Neurosci"},{"issue":"4","key":"10.3233\/JHD-190372_ref14","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1001\/archneur.65.4.482","article-title":"Rapid eye movement sleep disturbances in Huntington disease","volume":"65","author":"Arnulf","year":"2008","journal-title":"Arch Neurol"},{"key":"10.3233\/JHD-190372_ref15","doi-asserted-by":"crossref","first-page":"RRN1189","DOI":"10.1371\/currents.RRN1189","article-title":"Identifying sleep disturbances in Huntington\u2019s disease using a simple disease-focused questionnaire","volume":"2","author":"Goodman","year":"2010","journal-title":"PLoS Curr"},{"issue":"4","key":"10.3233\/JHD-190372_ref16","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1002\/ana.24495","article-title":"Sleep deficits but no metabolic deficits in premanifest Huntington\u2019s disease","volume":"78","author":"Lazar","year":"2015","journal-title":"Ann Neurol"},{"issue":"9","key":"10.3233\/JHD-190372_ref17","doi-asserted-by":"crossref","first-page":"1489","DOI":"10.5665\/sleep.4996","article-title":"Polysomnographic findings and clinical correlates in Huntington disease: A cross-sectional cohort study","volume":"38","author":"Piano","year":"2015","journal-title":"Sleep"},{"key":"10.3233\/JHD-190372_ref18","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.nbscr.2018.07.001","article-title":"Investigating the relationships between hypothalamic volume and measures of circadian rhythm and habitual sleep in premanifest Huntington\u2019s disease","volume":"6","author":"Bartlett","year":"2019","journal-title":"Neurobiol Sleep Circadian Rhythms"},{"issue":"5","key":"10.3233\/JHD-190372_ref19","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1212\/WNL.0b013e3181b04aa2","article-title":"Dietary intake in adults at risk for Huntington disease: Analysis of PHAROS research participants","volume":"73","author":"Marder","year":"2009","journal-title":"Neurology"},{"issue":"9","key":"10.3233\/JHD-190372_ref20","doi-asserted-by":"crossref","first-page":"1325","DOI":"10.1212\/01.WNL.0000031791.10922.CF","article-title":"Weight loss in early stage of Huntington\u2019s disease","volume":"59","author":"Djousse","year":"2002","journal-title":"Neurology"},{"issue":"3","key":"10.3233\/JHD-190372_ref21","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1002\/ana.25007","article-title":"Body weight is a robust predictor of clinical progression in Huntington disease","volume":"82","author":"van der Burg","year":"2017","journal-title":"Ann Neurol"},{"issue":"2","key":"10.3233\/JHD-190372_ref22","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.neubiorev.2005.04.020","article-title":"The limbic brain: Continuing resolution","volume":"30","author":"Morgane","year":"2006","journal-title":"Neurosci Biobehav Rev"},{"issue":"2","key":"10.3233\/JHD-190372_ref23","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.pneurobio.2005.01.001","article-title":"A review of systems and networks of the limbic forebrain\/limbic midbrain","volume":"75","author":"Morgane","year":"2005","journal-title":"Prog Neurobiol"},{"issue":"4","key":"10.3233\/JHD-190372_ref24","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1111\/j.1460-9568.2006.04985.x","article-title":"Hypothalamic-endocrine aspects in Huntington\u2019s disease","volume":"24","author":"Petersen","year":"2006","journal-title":"Eur J Neurosci"},{"issue":"10","key":"10.3233\/JHD-190372_ref25","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.2174\/1389450111007011237","article-title":"Hypothalamic and neuroendocrine changes in Huntington\u2019s disease","volume":"11","author":"Hult","year":"2010","journal-title":"Curr Drug Targets"},{"issue":"11","key":"10.3233\/JHD-190372_ref26","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1111\/jne.12190","article-title":"Hypothalamic alterations in Huntington\u2019s disease patients: Comparison with genetic rodent models","volume":"26","author":"van Wamelen","year":"2014","journal-title":"J Neuroendocrinol"},{"key":"10.3233\/JHD-190372_ref27","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1016\/j.neubiorev.2016.09.006","article-title":"Neuroendocrine and neurotrophic signaling in Huntington\u2019s disease: Implications for pathogenic mechanisms and treatment strategies","volume":"71","author":"Bartlett","year":"2016","journal-title":"Neurosci Biobehav Rev"},{"key":"10.3233\/JHD-190372_ref28","doi-asserted-by":"crossref","first-page":"5","DOI":"10.3233\/JHD-2012-120006","article-title":"Hypothalamic and limbic system changes in Huntington\u2019s disease","volume":"1","author":"Petersen","year":"2012","journal-title":"J Huntingtons Dis"},{"issue":"2","key":"10.3233\/JHD-190372_ref29","first-page":"213","article-title":"Topography of cerebral atrophy in early Huntington\u2019s disease: A voxel based morphometric MRI study","volume":"75","author":"Kassubek","year":"2004","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"4","key":"10.3233\/JHD-190372_ref30","doi-asserted-by":"crossref","first-page":"1562","DOI":"10.1016\/j.neuroimage.2006.05.057","article-title":"Distribution of grey matter atrophy in Huntington\u2019s disease patients: A combined ROI-based and voxel-based morphometric study","volume":"32","author":"Douaud","year":"2006","journal-title":"Neuroimage"},{"issue":"3","key":"10.3233\/JHD-190372_ref31","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1016\/j.nbd.2010.07.013","article-title":"Early changes in the hypothalamic region in prodromal Huntington disease revealed by MRI analysis","volume":"40","author":"Soneson","year":"2010","journal-title":"Neurobiol Dis"},{"issue":"Pt 11","key":"10.3233\/JHD-190372_ref32","doi-asserted-by":"crossref","first-page":"2860","DOI":"10.1093\/brain\/awn244","article-title":"Hypothalamic involvement in Huntington\u2019s disease: An in vivo PET study","volume":"131","author":"Politis","year":"2008","journal-title":"Brain"},{"issue":"2","key":"10.3233\/JHD-190372_ref33","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1002\/hbm.21008","article-title":"Microglial activation in regions related to cognitive function predicts disease onset in Huntington\u2019s disease: A multimodal imaging study","volume":"32","author":"Politis","year":"2011","journal-title":"Hum Brain Mapp"},{"issue":"2","key":"10.3233\/JHD-190372_ref34","doi-asserted-by":"crossref","first-page":"e0117593","DOI":"10.1371\/journal.pone.0117593","article-title":"Volumetric analysis of the hypothalamus in Huntington disease using 3T MRI: The IMAGE-HD Study","volume":"10","author":"Gabery","year":"2015","journal-title":"PLoS One"},{"issue":"6","key":"10.3233\/JHD-190372_ref35","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1007\/s00401-010-0742-6","article-title":"Changes in key hypothalamic neuropeptide populations in Huntington disease revealed by neuropathological analyses","volume":"120","author":"Gabery","year":"2010","journal-title":"Acta Neuropathol"},{"issue":"1","key":"10.3233\/JHD-190372_ref36","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/0304-3940(91)90443-W","article-title":"The hypothalamic lateral tuberal nucleus and the characteristics of neuronal loss in Huntington\u2019s disease","volume":"132","author":"Kremer","year":"1991","journal-title":"Neurosci Lett"},{"issue":"4","key":"10.3233\/JHD-190372_ref37","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1097\/00005072-199007000-00002","article-title":"Atrophy of the hypothalamic lateral tuberal nucleus in Huntington\u2019s disease","volume":"49","author":"Kremer","year":"1990","journal-title":"J Neuropathol Exp Neurol"},{"key":"10.3233\/JHD-190372_ref38","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/S0079-6123(08)64576-8","article-title":"The hypothalamic lateral tuberal nucleus: Normal anatomy and changes in neurological diseases","volume":"93","author":"Kremer","year":"1992","journal-title":"Prog Brain Res"},{"issue":"2","key":"10.3233\/JHD-190372_ref39","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/0006-8993(96)00080-7","article-title":"Somatostatin 1-12 immunoreactivity is decreased in the hypothalamic lateral tuberal nucleus of Huntington\u2019s disease patients","volume":"728","author":"Timmers","year":"1996","journal-title":"Brain Res"},{"issue":"6","key":"10.3233\/JHD-190372_ref40","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1111\/nan.12236","article-title":"Selective loss of oxytocin and vasopressin in the hypothalamus in early Huntington disease: A case study","volume":"41","author":"Gabery","year":"2015","journal-title":"Neuropathol Appl Neurobiol"},{"key":"10.3233\/JHD-190372_ref41","doi-asserted-by":"crossref","first-page":"195","DOI":"10.3389\/fnbeh.2018.00195","article-title":"Neurobiological aspects of face recognition: The role of oxytocin","volume":"12","author":"Lopatina","year":"2018","journal-title":"Front Behav Neurosci"},{"issue":"1-2","key":"10.3233\/JHD-190372_ref42","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/j.psychres.2012.09.022","article-title":"Emotional face recognition deficits and medication effects in pre-manifest through stage-II Huntington\u2019s disease","volume":"207","author":"Labuschagne","year":"2013","journal-title":"Psychiatr Res"},{"key":"10.3233\/JHD-190372_ref43","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.pnpbp.2017.09.023","article-title":"Oxytocin selectively modulates brain processing of disgust in Huntington\u2019s disease gene carriers","volume":"81","author":"Labuschagne","year":"2018","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"issue":"11","key":"10.3233\/JHD-190372_ref44","doi-asserted-by":"crossref","first-page":"4331","DOI":"10.1523\/JNEUROSCI.17-11-04331.1997","article-title":"Vasopressin\/serotonin interactions in the anterior hypothalamus control aggressive behavior in golden hamsters","volume":"17","author":"Ferris","year":"1997","journal-title":"J Neurosci"},{"issue":"2","key":"10.3233\/JHD-190372_ref45","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/j.pbb.2006.01.001","article-title":"Orally active vasopressin V1a receptor antagonist, SRX251, selectively blocks aggressive behavior","volume":"83","author":"Ferris","year":"2006","journal-title":"Pharmacol Biochem Behav"},{"issue":"2","key":"10.3233\/JHD-190372_ref46","first-page":"123","article-title":"Hypothalamic control of food intake in rats and cats","volume":"24","author":"Anand","year":"1951","journal-title":"Yale J Biol Med"},{"key":"10.3233\/JHD-190372_ref47","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1037\/h0039285","article-title":"The lateral hypothalamic syndrome: Recovery of feeding and drinking after lateral hypothalamic lesions","volume":"69","author":"Teitelbaum","year":"1962","journal-title":"Psychol Rev"},{"issue":"1","key":"10.3233\/JHD-190372_ref48","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1037\/h0076187","article-title":"Chronically reduced body weight in rats sustaining lesions of the lateral hypothalamus and maintained on palatable diets and drinking solutions","volume":"88","author":"Boyle","year":"1975","journal-title":"J Comp Physiol Psychol"},{"issue":"2","key":"10.3233\/JHD-190372_ref49","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1038\/nn.4220","article-title":"Lateral hypothalamic circuits for feeding and reward","volume":"19","author":"Stuber","year":"2016","journal-title":"Nat Neurosci"},{"issue":"1","key":"10.3233\/JHD-190372_ref50","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1093\/hmg\/ddi004","article-title":"Orexin loss in Huntington\u2019s disease","volume":"14","author":"Petersen","year":"2005","journal-title":"Hum Mol Genet"},{"issue":"4","key":"10.3233\/JHD-190372_ref51","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1111\/j.1750-3639.2008.00135.x","article-title":"Hypocretin and melanin-concentrating hormone in patients with Huntington disease","volume":"18","author":"Aziz","year":"2008","journal-title":"Brain Pathol"},{"issue":"4","key":"10.3233\/JHD-190372_ref52","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1111\/nan.12514","article-title":"SIRT1 is increased in affected brain regions and hypothalamic metabolic pathways are altered in Huntington disease","volume":"45","author":"Baldo","year":"2019","journal-title":"Neuropathol Appl Neurobiol"},{"key":"10.3233\/JHD-190372_ref53","doi-asserted-by":"crossref","first-page":"413","DOI":"10.3389\/fneur.2018.00413","article-title":"Hypocretin as a hub for arousal and motivation","volume":"9","author":"Tyree","year":"2018","journal-title":"Front Neurol"},{"key":"10.3233\/JHD-190372_ref54","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/bs.pbr.2017.08.005","article-title":"Functional roles of orexin\/hypo-cretin receptors in reward circuit","volume":"235","author":"Haghparast","year":"2017","journal-title":"Prog Brain Res"},{"key":"10.3233\/JHD-190372_ref55","first-page":"11","article-title":"The melanin-concentrating hormone as an integrative peptide driving motivated behaviors","author":"Diniz","year":"2017","journal-title":"Front Syst Neurosci"},{"issue":"2","key":"10.3233\/JHD-190372_ref56","first-page":"291","article-title":"Do disruptions in the circadian timing system contribute to autonomic dysfunction in Huntington\u2019s disease?","volume":"92","author":"Park","year":"2019","journal-title":"Yale J Biol Med"},{"issue":"1","key":"10.3233\/JHD-190372_ref57","first-page":"117","article-title":"Suprachiasmatic nucleus neuropeptide expression in patients with Huntington\u2019s disease","volume":"36","author":"van Wamelen","year":"2013","journal-title":"Sleep"},{"issue":"7","key":"10.3233\/JHD-190372_ref58","doi-asserted-by":"crossref","first-page":"2578","DOI":"10.1172\/JCI62848","article-title":"FOXO1 in the ventromedial hypothalamus regulates energy balance","volume":"122","author":"Kim","year":"2012","journal-title":"J Clin Invest"},{"issue":"7333","key":"10.3233\/JHD-190372_ref59","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1038\/nature09736","article-title":"Functional identification of an aggression locus in the mouse hypothalamus","volume":"470","author":"Lin","year":"2013","journal-title":"Nature"},{"issue":"11","key":"10.3233\/JHD-190372_ref60","doi-asserted-by":"crossref","first-page":"1431","DOI":"10.1111\/ejn.13239","article-title":"The ventromedial hypothalamus mediates predator fear memory","volume":"43","author":"Silva","year":"2016","journal-title":"Eur J Neurosci"},{"issue":"12","key":"10.3233\/JHD-190372_ref61","doi-asserted-by":"crossref","first-page":"1731","DOI":"10.1038\/nn.3573","article-title":"Independent hypothalamic circuits for social and predator fear","volume":"16","author":"Silva","year":"2013","journal-title":"Nat Neurosci"},{"issue":"17","key":"10.3233\/JHD-190372_ref62","doi-asserted-by":"crossref","first-page":"5971","DOI":"10.1523\/JNEUROSCI.5109-13.2014","article-title":"Decoding ventromedial hypothalamic neural activity during male mouse aggression","volume":"34","author":"Falkner","year":"2014","journal-title":"J Neurosci"},{"issue":"6","key":"10.3233\/JHD-190372_ref63","doi-asserted-by":"crossref","first-page":"1344","DOI":"10.1016\/j.neuron.2014.12.025","article-title":"Collateral pathways from the ventromedial hypothalamus mediate defensive behaviors","volume":"85","author":"Wang","year":"2015","journal-title":"Neuron"},{"key":"10.3233\/JHD-190372_ref64","first-page":"4","article-title":"Ventromedial hypothalamic neurons control a defensive emotion state","author":"Kunwar","year":"2015","journal-title":"Elife"},{"issue":"7","key":"10.3233\/JHD-190372_ref65","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1038\/nn1073","article-title":"Brain-derived neurotrophic factor regulates energy balance downstream of melanocortin-4 receptor","volume":"6","author":"Xu","year":"2003","journal-title":"Nat Neurosci"},{"issue":"26","key":"10.3233\/JHD-190372_ref66","doi-asserted-by":"crossref","first-page":"15239","DOI":"10.1073\/pnas.96.26.15239","article-title":"Brain-derived neurotrophic factor-deficient mice develop aggressiveness and hyperphagia in conjunction with brain serotonergic abnormalities","volume":"96","author":"Lyons","year":"1999","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"52","key":"10.3233\/JHD-190372_ref67","doi-asserted-by":"crossref","first-page":"14265","DOI":"10.1523\/JNEUROSCI.3308-07.2007","article-title":"Selective deletion of Bdnf in the ventromedial and dorsomedial hypothalamus of adult mice results in hyperphagic behavior and obesity","volume":"27","author":"Unger","year":"2007","journal-title":"J Neurosci"},{"issue":"5529","key":"10.3233\/JHD-190372_ref68","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1126\/science.1059581","article-title":"Loss of huntingtin-mediated BDNF gene transcription in Huntington\u2019s disease","volume":"293","author":"Zuccato","year":"2001","journal-title":"Science"},{"issue":"11","key":"10.3233\/JHD-190372_ref69","doi-asserted-by":"crossref","first-page":"2995","DOI":"10.1093\/hmg\/ddu010","article-title":"A potent and selective Sirtuin 1 inhibitor alleviates pathology in multiple animal and cell models of Huntington\u2019s disease","volume":"23","author":"Smith","year":"2014","journal-title":"Hum Mol Genet"},{"issue":"3","key":"10.3233\/JHD-190372_ref70","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1111\/bcp.12512","article-title":"An exploratory double-blind, randomized clinical trial with selisistat, a SirT1 inhibitor, in patients with Huntington\u2019s disease","volume":"79","author":"Sussmuth","year":"2015","journal-title":"Br J Clin Pharmacol"},{"issue":"40","key":"10.3233\/JHD-190372_ref71","doi-asserted-by":"crossref","first-page":"9989","DOI":"10.1523\/JNEUROSCI.3257-08.2008","article-title":"Brain SIRT Anatomical distribution and regulation by energy availability","volume":"28","author":"Ramadori","year":"2008","journal-title":"J Neurosci"},{"issue":"30","key":"10.3233\/JHD-190372_ref72","doi-asserted-by":"crossref","first-page":"10220","DOI":"10.1523\/JNEUROSCI.1385-10.2010","article-title":"SIRT1 promotes the central adaptive response to diet restriction through activation of the dorsomedial and lateral nuclei of the hypothalamus","volume":"30","author":"Satoh","year":"2010","journal-title":"J Neurosci"},{"issue":"3","key":"10.3233\/JHD-190372_ref73","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1016\/j.cmet.2013.07.013","article-title":"Sirt1 extends life span and delays aging in mice through the regulation of Nk2 homeobox 1 in the DMH and LH","volume":"18","author":"Satoh","year":"2013","journal-title":"Cell Metab"},{"key":"10.3233\/JHD-190372_ref74","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.mce.2016.09.002","article-title":"The metabolic sensor Sirt1 and the hypothalamus: Interplay between peptide hormones and pro-hormone convertases","volume":"438","author":"Nillni","year":"2016","journal-title":"Mol Cell Endocrinol"},{"issue":"47","key":"10.3233\/JHD-190372_ref75","doi-asserted-by":"crossref","first-page":"32845","DOI":"10.1074\/jbc.M114.612424","article-title":"Forkhead transcription factor FOXO3a levels are increased in Huntington disease because of overactivated positive autofeedback loop","volume":"289","author":"Kannike","year":"2014","journal-title":"J Biol Chem"},{"issue":"7","key":"10.3233\/JHD-190372_ref76","doi-asserted-by":"crossref","first-page":"e1006137","DOI":"10.1371\/journal.pgen.1006137","article-title":"Systems genetic analyses highlight a TGFbeta-FOXO3 dependent striatal astrocyte network conserved across species and associated with stress, sleep, and Huntington\u2019s disease","volume":"12","author":"Scarpa","year":"2016","journal-title":"PLoS Genet"},{"key":"10.3233\/JHD-190372_ref77","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1016\/j.nicl.2018.03.027","article-title":"Reduced amygdala volumes are related to motor and cognitive signs in Huntington\u2019s disease: The IMAGE-HD study","volume":"18","author":"Ahveninen","year":"2018","journal-title":"Neuroimage Clin"},{"issue":"3","key":"10.3233\/JHD-190372_ref78","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1007\/s00415-010-5768-0","article-title":"Early atrophy of pallidum and accumbens nucleus in Huntington\u2019s disease","volume":"258","author":"van den Bogaard","year":"2011","journal-title":"J Neurol"},{"issue":"10","key":"10.3233\/JHD-190372_ref79","doi-asserted-by":"crossref","first-page":"1615","DOI":"10.1212\/01.WNL.0000065888.88988.6E","article-title":"Evidence for more widespread cerebral pathology in early HD: An MRI-based morphometric analysis","volume":"60","author":"Rosas","year":"2003","journal-title":"Neurology"},{"issue":"7","key":"10.3233\/JHD-190372_ref80","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1002\/mds.27395","article-title":"Structural and metabolic brain correlates of apathy in Huntington\u2019s disease","volume":"33","author":"Martinez-Horta","year":"2018","journal-title":"Mov Disord"},{"issue":"5","key":"10.3233\/JHD-190372_ref81","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.1002\/hbm.24456","article-title":"Regional subcortical shape analysis in premanifest Huntington\u2019s disease","volume":"40","author":"Tang","year":"2019","journal-title":"Hum Brain Mapp"},{"issue":"14","key":"10.3233\/JHD-190372_ref82","doi-asserted-by":"crossref","first-page":"2544","DOI":"10.1002\/mds.23912","article-title":"Basal ganglia atrophy in prodromal Huntington\u2019s disease is detectable over one year using automated segmentation","volume":"26","author":"Majid","year":"2011","journal-title":"Mov Disord"},{"issue":"2","key":"10.3233\/JHD-190372_ref83","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1001\/archneur.1992.00530260052019","article-title":"Locus coeruleus involvement in Huntington\u2019s disease","volume":"49","author":"Zweig","year":"1992","journal-title":"Arch Neurol"},{"issue":"9","key":"10.3233\/JHD-190372_ref84","doi-asserted-by":"crossref","first-page":"1684","DOI":"10.1002\/mds.23747","article-title":"The structural involvement of the cingulate cortex in premanifest and early Huntington\u2019s disease","volume":"26","author":"Hobbs","year":"2011","journal-title":"Mov Disord"},{"issue":"2","key":"10.3233\/JHD-190372_ref85","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1136\/jnnp.2007.116244","article-title":"Longitudinal analysis of regional grey matter loss in Huntington disease: Effects of the length of the expanded CAG repeat","volume":"79","author":"Ruocco","year":"2008","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"3","key":"10.3233\/JHD-190372_ref86","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/j.parkreldis.2008.05.010","article-title":"Prefrontal cortex volume reduction on MRI in preclinical Huntington\u2019s disease relates to visuomotor performance and CAG number","volume":"15","author":"Gomez-Anson","year":"2009","journal-title":"Parkinsonism Relat Disord"},{"issue":"Pt 4","key":"10.3233\/JHD-190372_ref87","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1093\/brain\/awq047","article-title":"Cell loss in the motor and cingulate cortex correlates with symptomatology in Huntington\u2019s disease","volume":"133","author":"Thu","year":"2010","journal-title":"Brain"},{"issue":"3","key":"10.3233\/JHD-190372_ref88","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1001\/archpsyc.55.3.215","article-title":"Neuronal and glial somal size in the prefrontal cortex: A postmortem morphometric study of schizophrenia and Huntington disease","volume":"55","author":"Rajkowska","year":"1998","journal-title":"Arch Gen Psychiatry"},{"issue":"6","key":"10.3233\/JHD-190372_ref89","doi-asserted-by":"crossref","first-page":"1955","DOI":"10.1002\/hbm.24504","article-title":"Dynamic functional network connectivity in Huntington\u2019s disease and its associations with motor and cognitive measures","volume":"40","author":"Espinoza","year":"2019","journal-title":"Hum Brain Mapp"},{"issue":"11","key":"10.3233\/JHD-190372_ref90","doi-asserted-by":"crossref","first-page":"1180","DOI":"10.1111\/j.1468-1331.2008.02253.x","article-title":"Altered frontostriatal coupling in pre-manifest Huntington\u2019s disease: Effects of increasing cognitive load","volume":"15","author":"Wolf","year":"2008","journal-title":"Eur J Neurol"},{"issue":"9","key":"10.3233\/JHD-190372_ref91","doi-asserted-by":"crossref","first-page":"2161","DOI":"10.1002\/hbm.21348","article-title":"Brain activation and functional connectivity in premanifest Huntington\u2019s disease during states of intrinsic and phasic alertness","volume":"33","author":"Wolf","year":"2012","journal-title":"Hum Brain Mapp"},{"issue":"2","key":"10.3233\/JHD-190372_ref92","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1136\/jnnp.2006.098368","article-title":"Functional connectivity of the prefrontal cortex in Huntington\u2019s disease","volume":"78","author":"Thiruvady","year":"2007","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"4","key":"10.3233\/JHD-190372_ref93","doi-asserted-by":"crossref","first-page":"325","DOI":"10.3233\/JHD-150154","article-title":"Functional brain correlates of neuropsychiatric symptoms in presymptomatic Huntington\u2019s disease: The IMAGE-HD Study","volume":"4","author":"Poudel","year":"2015","journal-title":"J Huntingtons Dis"},{"issue":"6","key":"10.3233\/JHD-190372_ref94","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1002\/mds.22485","article-title":"Whole-brain atrophy as a measure of progression in premanifest and early Huntington\u2019s disease","volume":"24","author":"Henley","year":"2009","journal-title":"Mov Disord"},{"issue":"2","key":"10.3233\/JHD-190372_ref95","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1007\/s00415-009-0052-x","article-title":"Relationship between CAG repeat length and brain volume in premanifest and early Huntington\u2019s disease","volume":"256","author":"Henley","year":"2009","journal-title":"J Neurol"},{"issue":"1","key":"10.3233\/JHD-190372_ref96","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1016\/j.expneurol.2012.02.003","article-title":"Altered ventral striatal activation during reward and punishment processing in premanifest Huntington\u2019s disease: A functional magnetic resonance study","volume":"235","author":"Enzi","year":"2012","journal-title":"Exp Neurol"},{"key":"10.3233\/JHD-190372_ref97","doi-asserted-by":"crossref","unstructured":"Malejko K , Weydt P , Sussmuth SD , Gron G , Landwehrmeyer BG , Abler B . Prodromal Huntington disease as a model for functional compensation of early neurodegeneration. PLoS One. 2014;9(12).","DOI":"10.1371\/journal.pone.0114569"},{"key":"10.3233\/JHD-190372_ref98","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.neuropsychologia.2015.02.017","article-title":"The role of the amygdala during emotional processing in Huntington\u2019s disease: From pre-manifest to late stage disease","volume":"70","author":"Mason","year":"2015","journal-title":"Neuropsychologia"},{"key":"10.3233\/JHD-190372_ref99","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1016\/j.nicl.2016.10.009","article-title":"Early grey matter changes in structural covariance networks in Huntington\u2019s disease","volume":"12","author":"Coppen","year":"2016","journal-title":"Neuroimage Clin"},{"issue":"1","key":"10.3233\/JHD-190372_ref100","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1111\/j.1399-0004.2006.00636.x","article-title":"Cerebrospinal fluid levels of orexin-A are not a clinically useful biomarker for Huntington disease","volume":"70","author":"Bjorkqvist","year":"2006","journal-title":"Clin Genet"},{"issue":"9","key":"10.3233\/JHD-190372_ref101","doi-asserted-by":"crossref","first-page":"1232","DOI":"10.1007\/s00415-006-0146-7","article-title":"Hypocretin-1 (orexin A) levels are normal in Huntington\u2019s disease","volume":"253","author":"Baumann","year":"2006","journal-title":"J Neurol"},{"issue":"12","key":"10.3233\/JHD-190372_ref102","doi-asserted-by":"crossref","first-page":"1607","DOI":"10.1093\/sleep\/28.12.1607","article-title":"CSF hypocretin levels are normal in Huntington\u2019s disease patients","volume":"28","author":"Gaus","year":"2005","journal-title":"Sleep"},{"issue":"2","key":"10.3233\/JHD-190372_ref103","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/j.brainres.2005.09.028","article-title":"Normal hypocretin-1 (orexin-A) levels in the cerebrospinal fluid of patients with Huntington\u2019s disease","volume":"1063","author":"Meier","year":"2005","journal-title":"Brain Res"},{"issue":"10","key":"10.3233\/JHD-190372_ref104","doi-asserted-by":"crossref","first-page":"e0138848","DOI":"10.1371\/journal.pone.0138848","article-title":"A 24-hour study of the hypothalamo-pituitary axes in Huntington\u2019s disease","volume":"10","author":"Kalliolia","year":"2015","journal-title":"PLoS One"},{"issue":"13","key":"10.3233\/JHD-190372_ref105","doi-asserted-by":"crossref","first-page":"1952","DOI":"10.1002\/mds.21447","article-title":"Cocaine- and amphetamine-regulated transcript is increased in Huntington disease","volume":"22","author":"Bjorkqvist","year":"2007","journal-title":"Mov Disord"},{"issue":"10","key":"10.3233\/JHD-190372_ref106","doi-asserted-by":"crossref","first-page":"1713","DOI":"10.1093\/hmg\/ddl094","article-title":"Progressive alterations in the hypothalamic-pituitary-adrenal axis in the R6\/2 transgenic mouse model of Huntington\u2019s disease","volume":"15","author":"Bjorkqvist","year":"2006","journal-title":"Hum Mol Genet"},{"issue":"4","key":"10.3233\/JHD-190372_ref107","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1210\/jc.2008-2543","article-title":"Increased hypothalamic-pituitary-adrenal axis activity in Huntington\u2019s disease","volume":"94","author":"Aziz","year":"2009","journal-title":"J Clin Endocrinol Metab"},{"issue":"11","key":"10.3233\/JHD-190372_ref108","doi-asserted-by":"crossref","first-page":"2439","DOI":"10.1016\/j.psyneuen.2012.10.020","article-title":"Cortisol and depression in pre-diagnosed and early stage Huntington\u2019s disease","volume":"38","author":"Shirbin","year":"2013","journal-title":"Psychoneuroendocrinology"},{"issue":"3","key":"10.3233\/JHD-190372_ref109","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1111\/jne.12255","article-title":"Hypothalamic-pituitary-adrenal axis functioning in Huntington\u2019s disease and its association with depressive symptoms and suicidality","volume":"27","author":"Hubers","year":"2015","journal-title":"J Neuroendocrinol"},{"issue":"1","key":"10.3233\/JHD-190372_ref110","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.nbd.2007.07.029","article-title":"Increased metabolism in the R6\/2 mouse model of Huntington\u2019s disease","volume":"29","author":"van der Burg","year":"2008","journal-title":"Neurobiol Dis"},{"issue":"1-2","key":"10.3233\/JHD-190372_ref111","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.brainresbull.2007.12.007","article-title":"Increased thirst and drinking in Huntington\u2019s disease and the R6\/2 mouse","volume":"76","author":"Wood","year":"2008","journal-title":"Brain Res Bull"},{"issue":"11","key":"10.3233\/JHD-190372_ref112","doi-asserted-by":"crossref","first-page":"2099","DOI":"10.1093\/hmg\/ddq087","article-title":"Mutant huntingtin fragment selectively suppresses Brn-2 POU domain transcription factor to mediate hypothalamic cell dysfunction","volume":"19","author":"Yamanaka","year":"2010","journal-title":"Hum Mol Genet"},{"issue":"2","key":"10.3233\/JHD-190372_ref113","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1385\/JMN\/31:02:139","article-title":"Decreased VIP and VPAC2 receptor expression in the biological clock of the R6\/2 Huntington\u2019s disease mouse","volume":"31","author":"Fahrenkrug","year":"2007","journal-title":"J Mol Neurosci"},{"issue":"4","key":"10.3233\/JHD-190372_ref114","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1016\/j.cmet.2011.02.013","article-title":"Mutant huntingtin causes metabolic imbalance by disruption of hypothalamic neurocircuits","volume":"13","author":"Hult","year":"2011","journal-title":"Cell Metab"},{"key":"10.3233\/JHD-190372_ref115","doi-asserted-by":"crossref","first-page":"14598","DOI":"10.1038\/srep14598","article-title":"Hypothalamic overexpression of mutant huntingtin causes dysregulation of brown adipose tissue","volume":"5","author":"Soylu-Kucharz","year":"2015","journal-title":"Sci Rep"},{"key":"10.3233\/JHD-190372_ref116","doi-asserted-by":"crossref","first-page":"3485","DOI":"10.1093\/hmg\/ddt203","article-title":"Hypothalamic expression of mutant huntingtin contributes to the development of depressive-like behavior in the BAC transgenic mouse model of Huntington\u2019s disease","volume":"22","author":"Hult Lundh","year":"2013","journal-title":"Hum Mol Genet"},{"issue":"12","key":"10.3233\/JHD-190372_ref117","doi-asserted-by":"crossref","first-page":"e51168","DOI":"10.1371\/journal.pone.0051168","article-title":"Expression of mutant huntingtin in leptin receptor-expressing neurons does not control the metabolic and psychiatric phenotype of the BACHD mouse","volume":"7","author":"Lundh","year":"2012","journal-title":"PLoS One"},{"issue":"10","key":"10.3233\/JHD-190372_ref118","doi-asserted-by":"crossref","first-page":"e107691","DOI":"10.1371\/journal.pone.0107691","article-title":"Effects of deletion of mutant huntingtin in steroidogenic factor 1 neurons on the psychiatric and metabolic phenotype in the BACHD mouse model of Huntington disease","volume":"9","author":"Baldo","year":"2014","journal-title":"PLoS One"},{"key":"10.3233\/JHD-190372_ref119","doi-asserted-by":"crossref","first-page":"28322","DOI":"10.1038\/srep28322","article-title":"Metabolic and behavioral effects of mutant huntingtin deletion in Sim1 neurons in the BACHD mouse model of Huntington\u2019s disease","volume":"6","author":"Soylu-Kucharz","year":"2016","journal-title":"Sci Rep"},{"issue":"24","key":"10.3233\/JHD-190372_ref120","doi-asserted-by":"crossref","first-page":"2307","DOI":"10.1056\/NEJMoa1900907","article-title":"Targeting huntingtin expression in patients with Huntington\u2019s disease","volume":"380","author":"Tabrizi","year":"2019","journal-title":"N Engl J Med"},{"issue":"3","key":"10.3233\/JHD-190372_ref121","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1212\/WNL.62.3.523-a","article-title":"Evidence for more widespread cerebral pathology in early HD: An MRI-based morphometric analysis","volume":"62","author":"Kassubek","year":"2004","journal-title":"Neurology"},{"issue":"1","key":"10.3233\/JHD-190372_ref122","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.jns.2005.07.007","article-title":"Executive dysfunction in early stages of Huntington\u2019s disease is associated with striatal and insular atrophy: A neuropsychological and voxel-based morphometric study","volume":"239","author":"Peinemann","year":"2005","journal-title":"J Neurol Sci"},{"issue":"25","key":"10.3233\/JHD-190372_ref123","doi-asserted-by":"crossref","first-page":"9595","DOI":"10.1073\/pnas.0510197103","article-title":"Als2-deficient mice exhibit disturbances in endosome trafficking associated with motor behavioral abnormalities","volume":"103","author":"Devon","year":"2006","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"3","key":"10.3233\/JHD-190372_ref124","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1016\/j.nbd.2011.02.010","article-title":"Connecti-vity-based segmentation of the striatum in Huntington\u2019s disease: Vulnerability of motor pathways","volume":"42","author":"Bohanna","year":"2011","journal-title":"Neurobiol Dis"},{"issue":"5","key":"10.3233\/JHD-190372_ref125","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1016\/j.brainresbull.2010.08.006","article-title":"Hypothalamic-pituitary-adrenal axis functioning in Huntington\u2019s disease mutation carriers compared with mutation-negative first-degree controls","volume":"83","author":"van Duijn","year":"2010","journal-title":"Brain Res Bull"},{"issue":"9","key":"10.3233\/JHD-190372_ref126","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1016\/0006-3223(91)90007-9","article-title":"The limbic-hypothalamic-pituitary-adrenal axis in Huntington\u2019s disease","volume":"30","author":"Heuser","year":"1991","journal-title":"Biol Psychiatry"},{"key":"10.3233\/JHD-190372_ref127","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.parkreldis.2017.09.013","article-title":"Circadian rhythm and autonomic dysfunction in presymptomatic and early Huntington\u2019s disease","volume":"44","author":"Bellosta Diago","year":"2017","journal-title":"Parkinsonism Relat Disord"},{"issue":"2","key":"10.3233\/JHD-190372_ref128","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1111\/j.1365-2826.2012.02379.x","article-title":"Neuropeptide alterations in the infundibular nucleus of Huntington\u2019s disease patients","volume":"25","author":"van Wamelen","year":"2013","journal-title":"J Neuroendocrinol"},{"issue":"5","key":"10.3233\/JHD-190372_ref129","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1111\/j.1750-3639.2012.00565.x","article-title":"Paraventricular nucleus neuropeptide expression in Huntington\u2019s disease patients","volume":"22","author":"van Wamelen","year":"2012","journal-title":"Brain Pathol"},{"issue":"Suppl 3","key":"10.3233\/JHD-190372_ref130","doi-asserted-by":"crossref","first-page":"S387","DOI":"10.1016\/S1353-8020(08)70035-X","article-title":"Hypocretin-1 and secondary signs in Huntington\u2019s disease","volume":"13","author":"Roos","year":"2007","journal-title":"Parkinsonism Relat Disord"},{"issue":"1","key":"10.3233\/JHD-190372_ref131","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.nbd.2008.09.016","article-title":"Voxel-based morphometry in the R6\/2 transgenic mouse reveals differences between genotypes not seen with manual 2D morphometry","volume":"33","author":"Sawiak","year":"2009","journal-title":"Neurobiol Dis"},{"issue":"1","key":"10.3233\/JHD-190372_ref132","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.nbd.2008.09.017","article-title":"Use of magnetic resonance imaging for anatomical phenotyping of the R6\/2 mouse model of Huntington\u2019s disease","volume":"33","author":"Sawiak","year":"2009","journal-title":"Neurobiol Dis"},{"issue":"3","key":"10.3233\/JHD-190372_ref133","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1016\/j.nbd.2008.01.015","article-title":"Sertraline slows disease progression and increases neurogenesis in N171-82Q mouse model of Huntington\u2019s disease","volume":"30","author":"Duan","year":"2008","journal-title":"Neurobiol Dis"},{"issue":"3","key":"10.3233\/JHD-190372_ref134","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1016\/j.nbd.2005.05.006","article-title":"Reduced hippocampal neurogenesis in R6\/2 transgenic Huntington\u2019s disease mice","volume":"20","author":"Gil","year":"2005","journal-title":"Neurobiol Dis"},{"issue":"5","key":"10.3233\/JHD-190372_ref135","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1097\/00001756-200404090-00014","article-title":"Decreased hippocampal cell proliferation in R6\/1 Huntington\u2019s mice","volume":"15","author":"Lazic","year":"2004","journal-title":"Neuroreport"},{"issue":"1","key":"10.3233\/JHD-190372_ref136","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/j.expneurol.2007.10.015","article-title":"The antidepressant sertraline improves the phenotype, promotes neurogenesis and increases BDNF levels in the R6\/2 Huntington\u2019s disease mouse model","volume":"210","author":"Peng","year":"2008","journal-title":"Exp Neurol"},{"issue":"2","key":"10.3233\/JHD-190372_ref137","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/j.nbd.2010.09.012","article-title":"Altered adult hippocampal neurogenesis in the YAC128 transgenic mouse model of Huntington disease","volume":"41","author":"Simpson","year":"2011","journal-title":"Neurobiol Dis"},{"key":"10.3233\/JHD-190372_ref138","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.neuroscience.2010.08.022","article-title":"Neurogenesis in the R6\/2 mouse model of Huntington\u2019s disease is impaired at the level of NeuroD1","volume":"173","author":"Fedele","year":"2011","journal-title":"Neuroscience"},{"issue":"2","key":"10.3233\/JHD-190372_ref139","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1111\/j.1365-2826.2011.02238.x","article-title":"Deficits in spermatogenesis but not neurogenesis are alleviated by chronic testosterone therapy in R6\/1 Huntington\u2019s disease mice","volume":"24","author":"Hannan","year":"2012","journal-title":"J Neuroendocrinol"},{"issue":"5","key":"10.3233\/JHD-190372_ref140","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1002\/hipo.20658","article-title":"Wheel running and environmental enrichment differentially modify exon-specific BDNF expression in the hippocampus of wild-type and pre-motor symptomatic male and female Huntington\u2019s disease mice","volume":"20","author":"Zajac","year":"2010","journal-title":"Hippocampus"},{"issue":"1","key":"10.3233\/JHD-190372_ref141","doi-asserted-by":"crossref","first-page":"4272","DOI":"10.1038\/s41467-018-06675-3","article-title":"Modulation of AMPA receptor surface diffusion restores hippocampal plasticity and memory in Huntington\u2019s disease models","volume":"9","author":"Zhang","year":"2018","journal-title":"Nat Commun"},{"issue":"2","key":"10.3233\/JHD-190372_ref142","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1016\/j.neuroscience.2006.04.013","article-title":"Differential effects of voluntary physical exercise on behavioral and brain-derived neurotrophic factor expression deficits in Huntington\u2019s disease transgenic mice","volume":"141","author":"Pang","year":"2006","journal-title":"Neuroscience"},{"key":"10.3233\/JHD-190372_ref143","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1016\/j.nbd.2015.08.008","article-title":"Selective reduction of striatal mature BDNF without induction of proBDNF in the zQ175 mouse model of Huntington\u2019s disease","volume":"82","author":"Ma","year":"2015","journal-title":"Neurobiol Dis"},{"issue":"2","key":"10.3233\/JHD-190372_ref144","doi-asserted-by":"crossref","first-page":"267","DOI":"10.3233\/JHD-120024","article-title":"Direct visualisation of abnormal dendritic spine morphology in the hippocampus of the R6\/2 transgenic mouse model of Huntington\u2019s disease","volume":"1","author":"Bulley","year":"2012","journal-title":"J Huntingtons Dis"},{"issue":"10","key":"10.3233\/JHD-190372_ref145","doi-asserted-by":"crossref","first-page":"1074","DOI":"10.1002\/glia.20526","article-title":"Ferritin accumulation in dystrophic microglia is an early event in the development of Huntington\u2019s disease","volume":"55","author":"Simmons","year":"2007","journal-title":"Glia"},{"issue":"1","key":"10.3233\/JHD-190372_ref146","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1016\/j.expneurol.2006.10.014","article-title":"Reduced expression of PSA-NCAM in the hippocampus and piriform cortex of the R6\/1 and R6\/2 mouse models of Huntington\u2019s disease","volume":"204","author":"van der Borght","year":"2007","journal-title":"Exp Neurol"},{"issue":"3","key":"10.3233\/JHD-190372_ref147","doi-asserted-by":"crossref","first-page":"e18336","DOI":"10.1371\/journal.pone.0018336","article-title":"Altered dopamine and serotonin metabolism in motorically asymptomatic R6\/2 mice","volume":"6","author":"Mochel","year":"2011","journal-title":"PLoS One"},{"issue":"4","key":"10.3233\/JHD-190372_ref148","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1093\/hmg\/ddn385","article-title":"Altered serotonin receptor expression is associated with depression-related behavior in the R6\/1 transgenic mouse model of Huntington\u2019s disease","volume":"18","author":"Pang","year":"2009","journal-title":"Hum Mol Genet"},{"issue":"1","key":"10.3233\/JHD-190372_ref149","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.nlm.2010.11.010","article-title":"Altered emotional and motivational processing in the transgenic rat model for Huntington\u2019s disease","volume":"95","author":"Faure","year":"2011","journal-title":"Neurobiol Learn Mem"},{"issue":"Pt 5","key":"10.3233\/JHD-190372_ref150","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1093\/brain\/awg119","article-title":"Progressive striatal and cortical dopamine receptor dysfunction in Huntington\u2019s disease: A PET study","volume":"126","author":"Pavese","year":"2003","journal-title":"Brain"},{"issue":"4614","key":"10.3233\/JHD-190372_ref151","doi-asserted-by":"crossref","first-page":"972","DOI":"10.1126\/science.6136092","article-title":"Regional brain concentrations of neuropeptides in Huntington\u2019s chorea and schizophrenia","volume":"221","author":"Nemeroff","year":"1983","journal-title":"Science"},{"key":"10.3233\/JHD-190372_ref152","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.parkreldis.2017.11.001","article-title":"Grey matter volume loss is associated with specific clinical motor signs in Huntington\u2019s disease","volume":"46","author":"Coppen","year":"2018","journal-title":"Parkinsonism Relat Disord"},{"key":"10.3233\/JHD-190372_ref153","doi-asserted-by":"publisher","DOI":"10.1093\/cercor\/bhz009"},{"issue":"2","key":"10.3233\/JHD-190372_ref154","doi-asserted-by":"crossref","first-page":"e0192289","DOI":"10.1371\/journal.pone.0192289","article-title":"BACHD rats expressing full-length mutant huntingtin exhibit differences in social behavior compared to wild-type littermates","volume":"13","author":"Manfre","year":"2018","journal-title":"PLoS One"},{"key":"10.3233\/JHD-190372_ref155","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.neuroscience.2013.01.071","article-title":"Changes in brainstem serotonergic and dopaminergic cell populations in experimental and clinical Huntington\u2019s disease","volume":"238","author":"Jahanshahi","year":"2013","journal-title":"Neuroscience"},{"issue":"5","key":"10.3233\/JHD-190372_ref156","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1212\/WNL.34.5.663","article-title":"Somatostatin is increased in the nucleus accumbens in Huntington\u2019s disease","volume":"34","author":"Beal","year":"1984","journal-title":"Neurology"},{"key":"10.3233\/JHD-190372_ref157","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.brainres.2019.01.041","article-title":"Altered expression of dopaminergic cell fate regulating genes prior to manifestation of symptoms in a transgenic rat model of Huntington\u2019s disease","volume":"1712","author":"Huguet","year":"2019","journal-title":"Brain Res"},{"issue":"9","key":"10.3233\/JHD-190372_ref158","doi-asserted-by":"crossref","first-page":"910","DOI":"10.1097\/NEN.0b013e3181ee005d","article-title":"Hyperdopaminergic status in experimental Huntington disease","volume":"69","author":"Jahanshahi","year":"2010","journal-title":"J Neuropathol Exp Neurol"},{"key":"10.3233\/JHD-190372_ref159","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1186\/1471-2202-9-34","article-title":"Wheel running from a juvenile age delays onset of specific motor deficits but does not alter protein aggregate density in a mouse model of Huntington\u2019s disease","volume":"9","author":"van Dellen","year":"2008","journal-title":"BMC Neurosci"},{"issue":"6","key":"10.3233\/JHD-190372_ref160","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1002\/ana.20121","article-title":"Functional brain changes in presymptomatic Huntington\u2019s disease","volume":"55","author":"Reading","year":"2004","journal-title":"Ann Neurol"},{"issue":"5","key":"10.3233\/JHD-190372_ref161","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1017\/S1355617707071214","article-title":"fMRI detection of early neural dysfunction in preclinical Huntington\u2019s disease","volume":"13","author":"Zimbelman","year":"2007","journal-title":"J Int Neuropsychol Soc"},{"issue":"10","key":"10.3233\/JHD-190372_ref162","first-page":"1715","article-title":"fMRI biomarker of early neuronal dysfunction in presymptomatic Huntington\u2019s disease","volume":"25","author":"Paulsen","year":"2004","journal-title":"AJNR Am J Neuroradiol"},{"issue":"8","key":"10.3233\/JHD-190372_ref163","doi-asserted-by":"crossref","first-page":"1791","DOI":"10.1016\/j.neuropsychologia.2006.12.023","article-title":"Increased cortical recruitment in Huntington\u2019s disease using a Simon task","volume":"45","author":"Georgiou-Karistianis","year":"2007","journal-title":"Neuropsychologia"},{"issue":"1","key":"10.3233\/JHD-190372_ref164","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.bandc.2013.07.004","article-title":"Functional and connectivity changes during working memory in Huntington\u2019s disease: 18 month longitudinal data from the IMAGE-HD study","volume":"83","author":"Georgiou-Karistianis","year":"2013","journal-title":"Brain Cogn"},{"issue":"9","key":"10.3233\/JHD-190372_ref165","doi-asserted-by":"crossref","first-page":"2508","DOI":"10.1093\/hmg\/ddv016","article-title":"Early white matter abnormalities, progressive brain pathology and motor deficits in a novel knock-in mouse model of Huntington\u2019s disease","volume":"24","author":"Jin","year":"2015","journal-title":"Hum Mol Genet"},{"issue":"3","key":"10.3233\/JHD-190372_ref166","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1007\/s00702-006-0571-x","article-title":"Voxel-based morphometry indicates relative preservation of the limbic prefrontal cortex in early Huntington disease","volume":"114","author":"Muhlau","year":"2007","journal-title":"J Neural Transm (Vienna)"},{"issue":"10","key":"10.3233\/JHD-190372_ref167","doi-asserted-by":"crossref","first-page":"3717","DOI":"10.1002\/hbm.22835","article-title":"Prefrontal cortex white matter tracts in prodromal Huntington disease","volume":"36","author":"Matsui","year":"2015","journal-title":"Hum Brain Mapp"},{"key":"10.3233\/JHD-190372_ref168","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.neuroscience.2017.05.042","article-title":"Myelin breakdown in human Huntington\u2019s disease: Multi-modal evidence from diffusion MRI and quantitative magnetization transfer","volume":"403","author":"Bourbon-Teles","year":"2019","journal-title":"Neuroscience"},{"issue":"Pt 11","key":"10.3233\/JHD-190372_ref169","doi-asserted-by":"crossref","first-page":"2845","DOI":"10.1093\/brain\/awm210","article-title":"Dorsolateral prefrontal cortex dysfunction in presymptomatic Huntington\u2019s disease: Evidence from event-related fMRI","volume":"130","author":"Wolf","year":"2007","journal-title":"Brain"},{"issue":"2","key":"10.3233\/JHD-190372_ref170","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1016\/j.nbd.2011.04.009","article-title":"Reduced expression of conditioned fear in the R6\/2 mouse model of Huntington\u2019s disease is related to abnormal activity in prelimbic cortex","volume":"43","author":"Walker","year":"2011","journal-title":"Neurobiol Dis"},{"issue":"24","key":"10.3233\/JHD-190372_ref171","doi-asserted-by":"crossref","first-page":"8986","DOI":"10.1523\/JNEUROSCI.1238-11.2011","article-title":"Behavioral and in vivo electrophysiological evidence for presymptomatic alteration of prefrontostriatal processing in the transgenic rat model for huntington disease","volume":"31","author":"Hohn","year":"2011","journal-title":"J Neurosci"},{"issue":"5","key":"10.3233\/JHD-190372_ref172","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1007\/s11068-004-0514-8","article-title":"Early changes in Huntington\u2019s disease patient brains involve alterations in cytoskeletal and synaptic elements","volume":"33","author":"DiProspero","year":"2004","journal-title":"J Neurocytol"},{"issue":"17","key":"10.3233\/JHD-190372_ref173","doi-asserted-by":"crossref","first-page":"4510","DOI":"10.1093\/hmg\/ddu166","article-title":"Progressive axonal transport and synaptic protein changes correlate with behavioral and neuropathological abnormalities in the heterozygous Q175 KI mouse model of Huntington\u2019s disease","volume":"23","author":"Smith","year":"2014","journal-title":"Hum Mol Genet"},{"issue":"2","key":"10.3233\/JHD-190372_ref174","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1007\/s11064-007-9463-1","article-title":"Glutamate uptake is reduced in prefrontal cortex in Huntington\u2019s disease","volume":"33","author":"Hassel","year":"2008","journal-title":"Neurochem Res"},{"issue":"2","key":"10.3233\/JHD-190372_ref175","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1111\/j.1750-3639.2007.00111.x","article-title":"Systematic assessment of BDNF and its receptor levels in human cortices affected by Huntington\u2019s disease","volume":"18","author":"Zuccato","year":"2008","journal-title":"Brain Pathol"},{"issue":"3","key":"10.3233\/JHD-190372_ref176","doi-asserted-by":"crossref","first-page":"e4962","DOI":"10.1371\/journal.pone.0004962","article-title":"Neuroendocrine disturbances in Huntington\u2019s disease","volume":"4","author":"Saleh","year":"2009","journal-title":"PLoS One"},{"key":"10.3233\/JHD-190372_ref177","doi-asserted-by":"crossref","first-page":"231","DOI":"10.3389\/fphys.2014.00231","article-title":"Metabolic and hormonal signatures in pre-manifest and manifest Huntington\u2019s disease patients","volume":"5","author":"Wang","year":"2014","journal-title":"Front Physiol"},{"issue":"1","key":"10.3233\/JHD-190372_ref178","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/0022-510X(95)00114-H","article-title":"Serum dehydroepiandrosterone and cortisol measurements in Huntington\u2019s chorea","volume":"132","author":"Leblhuber","year":"1995","journal-title":"J Neurol Sci"},{"issue":"4","key":"10.3233\/JHD-190372_ref179","first-page":"539","article-title":"Circadian rhythms of melatonin and cortisol in manifest Huntington\u2019s disease and in acute cortical ischemic stroke","volume":"68","author":"Adamczak-Ratajczak","year":"2017","journal-title":"J Physiol Pharmacol"},{"issue":"5","key":"10.3233\/JHD-190372_ref180","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1111\/j.1476-5381.2011.01567.x","article-title":"Treatment of depressive-like behaviour in Huntington\u2019s disease mice by chronic sertraline and exercise","volume":"165","author":"Renoir","year":"2012","journal-title":"Br J Pharmacol"},{"key":"10.3233\/JHD-190372_ref181","first-page":"63","article-title":"The influence of the HPG axis on stress response and depressive-like behaviour in a transgenic mouse model of Huntington\u2019s disease","volume":"263C","author":"Du","year":"2014","journal-title":"Exp Neurol"},{"issue":"2","key":"10.3233\/JHD-190372_ref182","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1111\/j.1468-1331.2009.02798.x","article-title":"Growth hormone and ghrelin secretion are associated with clinical severity in Huntington\u2019s disease","volume":"17","author":"Aziz","year":"2010","journal-title":"Eur J Neurol"},{"issue":"4","key":"10.3233\/JHD-190372_ref183","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1530\/eje.0.1510451","article-title":"Circulating and cerebrospinal fluid ghrelin and leptin: Potential role in altered body weight in Huntington\u2019s disease","volume":"151","author":"Popovic","year":"2004","journal-title":"Eur J Endocrinol"},{"issue":"10","key":"10.3233\/JHD-190372_ref184","doi-asserted-by":"crossref","first-page":"2219","DOI":"10.1093\/hmg\/dds037","article-title":"Marked differences in neurochemistry and aggregates despite similar behavioural and neuropathological features of Huntington disease in the full-length BACHD and YAC128 mice","volume":"21","author":"Pouladi","year":"2012","journal-title":"Hum Mol Genet"},{"issue":"5","key":"10.3233\/JHD-190372_ref185","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1111\/jnc.13624","article-title":"Neuropeptide Y (NPY) in cerebrospinal fluid from patients with Huntington\u2019s disease: Increased NPY levels and differential degradation of the NPY1-30 fragment","volume":"137","author":"Wagner","year":"2016","journal-title":"J Neurochem"},{"issue":"4","key":"10.3233\/JHD-190372_ref186","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1111\/j.1365-2265.2010.03836.x","article-title":"Altered thyrotropic and lactotropic axes regulation in Huntington\u2019s disease","volume":"73","author":"Aziz","year":"2010","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"5","key":"10.3233\/JHD-190372_ref187","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1007\/s11064-008-9851-1","article-title":"Plasma homovanillic acid and prolactin in Huntington\u2019s disease","volume":"34","author":"Markianos","year":"2009","journal-title":"Neurochem Res"},{"issue":"2","key":"10.3233\/JHD-190372_ref188","first-page":"199","article-title":"Plasma testosterone, dehydroepiandrosterone sulfate, and cortisol in female patients with Huntington\u2019s disease","volume":"28","author":"Markianos","year":"2007","journal-title":"Neuro Endocrinol Lett"},{"issue":"6","key":"10.3233\/JHD-190372_ref189","doi-asserted-by":"crossref","first-page":"1541","DOI":"10.1111\/j.1460-9568.2005.04324.x","article-title":"Reduction of GnRH and infertility in the R6\/2 mouse model of Huntington\u2019s disease","volume":"22","author":"Papalexi","year":"2005","journal-title":"Eur J Neurosci"},{"issue":"17","key":"10.3233\/JHD-190372_ref190","doi-asserted-by":"crossref","first-page":"2595","DOI":"10.1093\/hmg\/ddn159","article-title":"Sex differences in a transgenic rat model of Huntington\u2019s disease: Decreased 17beta-estradiol levels correlate with reduced numbers of DARPP32+ neurons in males","volume":"17","author":"Bode","year":"2008","journal-title":"Hum Mol Genet"},{"issue":"4","key":"10.3233\/JHD-190372_ref191","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1002\/ana.20428","article-title":"Plasma testosterone in male patients with Huntington\u2019s disease: Relations to severity of illness and dementia","volume":"57","author":"Markianos","year":"2005","journal-title":"Ann Neurol"},{"issue":"2","key":"10.3233\/JHD-190372_ref192","doi-asserted-by":"crossref","first-page":"318","DOI":"10.2337\/db08-0799","article-title":"Exendin-4 improves glycemic control, ameliorates brain and pancreatic pathologies, and extends survival in a mouse model of Huntington\u2019s disease","volume":"58","author":"Martin","year":"2009","journal-title":"Diabetes"},{"issue":"1","key":"10.3233\/JHD-190372_ref193","doi-asserted-by":"crossref","first-page":"8961","DOI":"10.1038\/s41598-018-27121-w","article-title":"Dual therapy with liraglutide and ghrelin promotes brain and peripheral energy metabolism in the R6\/2 mouse model of Huntington\u2019s disease","volume":"8","author":"Duarte","year":"2018","journal-title":"Sci Rep"},{"issue":"1","key":"10.3233\/JHD-190372_ref194","doi-asserted-by":"crossref","first-page":"13896","DOI":"10.1038\/s41598-017-13713-5","article-title":"Ghrelin rescues skeletal muscle catabolic profile in the R6\/2 mouse model of Huntington\u2019s disease","volume":"7","author":"Sjogren","year":"2017","journal-title":"Sci Rep"},{"issue":"2","key":"10.3233\/JHD-190372_ref195","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1111\/j.1365-2826.2007.01629.x","article-title":"Impaired glucose tolerance in the R6\/1 transgenic mouse model of Huntington\u2019s disease","volume":"20","author":"Josefsen","year":"2008","journal-title":"J Neuroendocrinol"},{"issue":"11","key":"10.3233\/JHD-190372_ref196","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.1136\/jnnp.2009.191833","article-title":"Systemic energy homeostasis in Huntington\u2019s disease patients","volume":"81","author":"Aziz","year":"2010","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"2","key":"10.3233\/JHD-190372_ref197","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1111\/j.1365-2265.2009.03661.x","article-title":"Leptin secretion rate increases with higher CAG repeat number in Huntington\u2019s disease patients","volume":"73","author":"Aziz","year":"2010","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.3233\/JHD-190372_ref198","first-page":"5","article-title":"Increased body weight of the BAC HD transgenic mouse model of Huntington\u2019s disease accounts for some but not all of the observed HD-like motor deficits","author":"Kudwa","year":"2013","journal-title":"PLoS Curr"},{"issue":"1","key":"10.3233\/JHD-190372_ref199","doi-asserted-by":"crossref","first-page":"17","DOI":"10.3233\/JHD-140116","article-title":"Novel BAC mouse model of Huntington\u2019s disease with 225 CAG repeats exhibits an early widespread and stable degenerative phenotype","volume":"4","author":"Wegrzynowicz","year":"2015","journal-title":"J Huntingtons Dis"},{"issue":"6","key":"10.3233\/JHD-190372_ref200","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1093\/hmg\/ddn428","article-title":"Adipose tissue dysfunction tracks disease progression in two Huntington\u2019s disease mouse models","volume":"18","author":"Phan","year":"2009","journal-title":"Hum Mol Genet"},{"issue":"3","key":"10.3233\/JHD-190372_ref201","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1038\/jcbfm.2011.157","article-title":"Cortical metabolites as biomarkers in the R6\/2 model of Huntington\u2019s disease","volume":"32","author":"Zacharoff","year":"2012","journal-title":"J Cereb Blood Flow Metab"},{"issue":"17","key":"10.3233\/JHD-190372_ref202","doi-asserted-by":"crossref","first-page":"6956","DOI":"10.1523\/JNEUROSCI.23-17-06956.2003","article-title":"Lack of huntingtin-associated protein-1 causes neuronal death resembling hypothalamic degeneration in Huntington\u2019s disease","volume":"23","author":"Li","year":"2003","journal-title":"J Neurosci"},{"issue":"1","key":"10.3233\/JHD-190372_ref203","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.expneurol.2010.12.011","article-title":"Dysfunctions in circadian behavior and physiology in mouse models of Huntington\u2019s disease","volume":"228","author":"Kudo","year":"2011","journal-title":"Exp Neurol"},{"issue":"2","key":"10.3233\/JHD-190372_ref204","doi-asserted-by":"crossref","first-page":"e0147583","DOI":"10.1371\/journal.pone.0147583","article-title":"Sex differences in circadian dysfunction in the BACHD mouse model of Huntington\u2019s disease","volume":"11","author":"Kuljis","year":"2016","journal-title":"PLoS One"},{"key":"10.3233\/JHD-190372_ref205","doi-asserted-by":"crossref","unstructured":"Loh DH , Kudo T , Truong D , Wu YF , Colwell CS . The Q175 mouse model of Huntington\u2019s disease shows gene dosage- and age-related decline in circadian rhythms of activity and sleep. PLoS One. 2013;8(7).","DOI":"10.1371\/journal.pone.0069993"},{"key":"10.3233\/JHD-190372_ref206","unstructured":"Wang HB , Loh DH , Whittaker DS , Cutler T , Howland D , Colwell CS . Time-restricted feeding improves circadian dysfunction as well as motor symptoms in the Q175 mouse model of Huntington\u2019s Disease. Eneuro. 2018;5(1), ENEURO.0431-17.2017."},{"issue":"1","key":"10.3233\/JHD-190372_ref207","doi-asserted-by":"crossref","first-page":"e0147269","DOI":"10.1371\/journal.pone.0147269","article-title":"Cardiac dysfunction in the BACHD mouse model of Huntington\u2019s disease","volume":"11","author":"Schroeder","year":"2016","journal-title":"PLoS One"},{"issue":"3","key":"10.3233\/JHD-190372_ref208","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1111\/j.1471-4159.2005.03035.x","article-title":"Decreased expression of hypothalamic neuropeptides in Huntington disease transgenic mice with expanded polyglutamine-EGFP fluorescent aggregates","volume":"93","author":"Kotliarova","year":"2005","journal-title":"J Neurochem"},{"issue":"30","key":"10.3233\/JHD-190372_ref209","doi-asserted-by":"crossref","first-page":"10199","DOI":"10.1523\/JNEUROSCI.1694-10.2010","article-title":"Disruption of peripheral circadian timekeeping in a mouse model of Huntington\u2019s disease and its restoration by temporally scheduled feeding","volume":"30","author":"Maywood","year":"2010","journal-title":"J Neurosci"},{"issue":"29","key":"10.3233\/JHD-190372_ref210","doi-asserted-by":"crossref","first-page":"7869","DOI":"10.1523\/JNEUROSCI.0649-07.2007","article-title":"Pharmacological imposition of sleep slows cognitive decline and reverses dysregulation of circadian gene expression in a transgenic mouse model of Huntington\u2019s disease","volume":"27","author":"Pallier","year":"2007","journal-title":"J Neurosci"},{"issue":"3","key":"10.3233\/JHD-190372_ref211","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1016\/j.nbd.2011.02.006","article-title":"Paradoxical function of orexin\/hypocretin circuits in a mouse model of Huntington\u2019s disease","volume":"42","author":"Williams","year":"2011","journal-title":"Neurobiol Dis"}],"container-title":["Journal of Huntington's Disease"],"original-title":[],"link":[{"URL":"https:\/\/content.iospress.com\/download?id=10.3233\/JHD-190372","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T08:50:55Z","timestamp":1777452655000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/full\/10.3233\/JHD-190372"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,10,24]]},"references-count":211,"journal-issue":{"issue":"4"},"URL":"https:\/\/doi.org\/10.3233\/jhd-190372","relation":{},"ISSN":["1879-6397","1879-6400"],"issn-type":[{"value":"1879-6397","type":"print"},{"value":"1879-6400","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,10,24]]}}}